CompoAtlas

Léro Transifine

Food supplement declared in France, declaration No 2017-10-418

Léro Transifine (Laboratoire Léro) is a food supplement declared in France. Status: retrait du marché annoncé pour le 2 January 2028. 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
Laboratoire Léro
Food business operator placing the product on the market
DOMES PHARMA FR
Status
Retrait du marché annoncé pour le 2 January 2028
Form
Gélule
Daily dose
1 gélule
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Enfants (moins de 12 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Transit

Declaration 269047, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Prunus domestica L.FruitExtrait sec aqueux100 mg
Tamarindus indica L.Fruit (pulpe)Extrait sec aqueux100 mg

Other active ingredients

NamePer day
Fructo-oligosaccharidesnot declared

Additives

E440, E460, E470b, E464, E141

Other ingredients

maltodextrine, Concentré de riz

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Laboratoire Léro

Enter to analyse, Shift+Enter for a new line